한글목차

유착 방지제 시장은 2023년 7억 달러로 평가되며, 2024-2033년 연평균 7.8% 성장하여 2033년에는 15억 달러에 달할 것으로 예상됩니다.

유착 방지제는 수술 중 유착 형성의 위험을 줄여주는 의료용 임플란트입니다. 유착은 수술 후 발생할 수 있는 조직이나 장기 사이의 비정상적인 결합입니다. 유착과 관련된 다른 합병증으로는 장폐색, 불임, 만성 통증 등이 있으며, 치유 과정에서 조직이 서로 유착되어 발생할 수 있습니다. 유착을 방지하기 위해 유착 방지제는 조직 사이에 일시적인 장벽을 만듭니다.

세계 유착 방지제 시장의 성장은 수술 후 유착 위험이 심각하게 증가하고 있기 때문입니다. 한 연구에 따르면, 93%의 사람들이 한 번 이상의 복부 수술 후 유착이 발생했다고 합니다. 또한, 유착으로 인한 합병증에 대한 의료진의 인식이 높아지고, 혁신적인 유착 방지 제품의 개발이 세계 시장 성장에 크게 기여하고 있습니다. 연구자 및 제조업체들은 생체흡수성 재료로 만든 유착 방지제를 개발하는 데 주력하고 있으며, 이 유착 방지제는 점차 체내에 흡수되어 박리 절차가 필요 없게 됩니다. 예를 들어, 선도적인 의료 솔루션 제공업체 중 하나인 박스터 어드밴스드 서지컬 서저리(Baxter Advanced Surgery)는 세프라필름(Seprafilm) 유착 방지제를 개발했습니다. 이 유착 방지제는 두 가지 음이온성 다당류인 변성 히알루론산나트륨과 카르복시메틸셀룰로오스로 구성된 무균, 생체흡수성, 반투명, 친수성 유착 방지제입니다. 이 유착 방지제는 유착의 범위, 발생률 및 심각성을 크게 줄일 수 있습니다. 무작위, 전향적, 이중맹검, 다기관 임상연구는 궤양성 대장염과 친숙한 용종증을 앓고 있으며 2단계 장 절제술을 받은 환자 183명을 대상으로 진행되었습니다. 이 중 세프라필름 유착 방지제를 사용한 그룹은 51%의 환자에서 유착이 발생하지 않은 반면, 대조군에서는 수술 후 8-12주 동안 6%의 환자에서 유착이 발생했습니다. 또한, 유착 방지제가 포함된 수술에 대한 보험급여 정책의 증가는 유착 방지제의 사용을 촉진하여 세계 시장 성장을 촉진하고 있습니다. 그러나 현재 진행 중인 연구에도 불구하고 수술 후 유착을 예방하기 위해 널리 사용되는 특정 유착 방지제는 존재하지 않으며, 이는 시장의 주요 저해요인으로 작용하고 있습니다. 반대로 의료진은 유착 관련 합병증의 위험을 최소화하기 위해 유착 방지제를 수술 프로토콜에 통합하고 있으며, 이는 세계 수요를 견인할 것으로 예상됩니다. 또한, 의료 협회 및 의료 단체의 유착 예방 및 관리에 대한 인식을 높이고 지침을 수립하기 위한 이니셔티브가 증가함에 따라 예측 기간 동안 세계 시장 확대에 유익한 기회를 제공할 것으로 예상됩니다.

세계 유착 방지제 시장은 유형, 용도, 최종사용자, 지역별로 분류됩니다. 유형별로 시장은 합성 유착 방지제와 천연 유착 방지제로 분류됩니다. 용도별로는 일반/복부 수술, 부인과 수술, 심혈관 수술, 정형외과, 신경외과, 기타로 분류됩니다. 최종사용자에 따라 병원, 전문 클리닉, 외래 수술 센터로 세분화됩니다. 지역별로는 북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카로 분석됩니다.

주요 조사 결과

• 제품 유형별로는 합성 유착 방지제 부문이 2023년 점유율로 시장을 장악했습니다.
• 용도별로는 일반/복부 수술 부문이 2023년 주요 주주였습니다.
• 최종사용자별로는 병원 부문이 2023년 가장 큰 점유율을 차지했습니다.
• 북미가 큰 비중을 차지하고 있습니다.

경쟁 상황

본 보고서의 커스터마이징이 가능합니다(추가 비용과 일정이 필요합니다.)

• 제품/부문별 시장 세분화
• 국가별 또는 지역별 추가 분석 - 시장 규모 및 전망
• 평균 판매가격 분석/가격대 분석
• 기업 개요 확대 목록
• 과거 시장 데이터

목차

제1장 소개

제2장 주요 요약

제3장 시장 상황

• 시장 정의와 범위
• 주요 조사 결과
  • 주요 투자 기회
  • 주요 성공 전략
• Porter's Five Forces 분석
• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회

제4장 유착 방지제 시장 : 유형별

• 시장 개요
• 합성 유착 방지제
• 천연 유착 방지제

제5장 유착 방지제 시장 : 용도별

• 시장 개요
• 일반외과/복부외과
• 부인과 수술
• 심혈관외과
• 정형외과
• 신경외과
• 기타

제6장 유착 방지제 시장 : 최종사용자별

• 시장 개요
• 병원
• 전문 클리닉
• 외래 수술 센터

제7장 유착 방지제 시장 : 지역별

• 시장 개요
• 북미
  • 주요 시장 동향과 기회
  • 미국의 유착 방지제 시장
  • 캐나다의 유착 방지제 시장
  • 멕시코의 유착 방지제 시장
• 유럽
  • 주요 시장 동향과 기회
  • 독일의 유착 방지제 시장
  • 프랑스의 유착 방지제 시장
  • 영국의 유착 방지제 시장
  • 이탈리아의 유착 방지제 시장
  • 스페인의 유착 방지제 시장
  • 기타 유럽의 유착 방지제 시장
• 아시아태평양
  • 주요 시장 동향과 기회
  • 일본의 유착 방지제 시장
  • 중국의 유착 방지제 시장
  • 호주의 유착 방지제 시장
  • 인도의 유착 방지제 시장
  • 한국의 유착 방지제 시장
  • 기타 아시아태평양의 유착 방지제 시장
• 라틴아메리카, 중동 및 아프리카
  • 주요 시장 동향과 기회
  • 브라질의 유착 방지제 시장
  • 사우디아라비아의 유착 방지제 시장
  • 남아프리카공화국의 유착 방지제 시장
  • 기타 라틴아메리카, 중동 및 아프리카의 유착 방지제 시장

제8장 경쟁 상황

• 소개
• 주요 성공 전략
• 주요 10개 기업 제품 매핑
• 경쟁 대시보드
• 경쟁 히트맵
• 주요 기업의 포지셔닝(2023년)

제9장 기업 개요

• Anika Therapeutics Inc.
• Baxter International Inc.
• Leader Biomedical
• Betatech Medical
• Fziomed, Inc.
• Integra LifeSciences Holdings Corporation
• Johnson And Johnson
• CGBio Inc
• Atrium Medical Corporation
• Toray Industries Inc.

영문목차

The adhesion barrier market was valued at $0.7 billion in 2023, and is projected to reach $1.5 billion by 2033, growing at a CAGR of 7.8% from 2024 to 2033.

Adhesion barrier is a medical implant that alleviates the risk of adhesion formation during surgeries. Adhesion is an abnormal connections between tissues or organs that can occur after surgery. Other complications associated with adhesion include bowel obstructions, infertility, and chronic pain, which can arise when tissues stick together while healing. To prevent them from sticking, adhesion barriers create a temporary barrier between the tissues.

The growth of the global adhesion barrier market is driven by alarming rise in the risk of post-surgical adhesions. According to a study, 93% of individuals develop adhesions following one or more abdominal operations. Moreover, increase in awareness among healthcare professionals about the complications associated with adhesions and development of innovative adhesion barrier products notably contribute toward the growth of the global market. Researchers and manufacturers are focusing on the development of adhesion barriers made from bioresorbable materials, which are absorbed by the body gradually, thereby eliminating the need for removal procedures. For instance, Baxter Advanced Surgery, one of the leading providers of healthcare solutions, developed Seprafilm adhesion barrier, which is a sterile, bioresorbable, translucent, and hydrophilic adhesion barrier composed of two anionic polysaccharides, modified sodium hyaluronate and carboxymethylcellulose. This adhesion barrier is capable of significantly reducing the extent, incidence, and severity of adhesions. A randomized, prospective, double-blinded, multicenter clinical study involved 183 patients suffering from ulcerative colitis and familiar polyposis who underwent 2-stage intestinal resection surgery. Among these, 51% of the patients of the Seprafilm Adhesion Barrier group were adhesion-free compared to 6% of control patients post at 8-12 weeks of surgery. Furthermore, increase in reimbursement policies for surgical procedures involving adhesion barriers encourage their use, which boosts the growth of the global market. However, there is no specific adhesion barrier that is widely used to prevent post-surgical adhesions, despite ongoing research, which acts as a key deterrent factor of the market. On the contrary, healthcare professionals are incorporating the use of adhesion barriers into their surgical protocols to minimize the risk of adhesion-related complications, which is expected to drive their demand globally. Moreover, rise in initiatives to spread awareness and establish guidelines regarding the prevention and management of adhesions by medical societies and healthcare organizations is anticipated to offer remunerative opportunities for the expansion of the global market during the forecast period.

The global adhesion barrier market is segmented into type, application, end user, and region. On the basis of type, the market is categorized into synthetic adhesion barrier, and natural adhesion barrier. Depending on application, it is segregated into general/abdominal surgeries, gynecological surgeries, cardiovascular surgeries, orthopedic surgeries, neurological surgeries, and others. By end user, it is fragmented into hospitals, Specialty Clinics, Ambulatory Surgical Centers. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

• By product type, the synthetic adhesion barrier segment dominated the market, in terms of share in 2023.
• Depending on application, the general/abdominal surgeries segment was the major shareholder in 2023.
• On the basis of end user, the hospital segment acquired the maximum share in 2023.
• North America holds a significant share of the market.

Competitive Landscape

The competitive analysis and profiles of the major players in the global adhesion barrier market include Anika Therapeutics Inc., Baxter International Inc., leader biomedical, Betatech Medical, Fziomed, Inc., Integra LifeSciences Holdings Corporation, Johnson & Johnson, CGBio Inc., Atrium Medical Corporation, and Toray Industry Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, which strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Market share analysis of players by products/segments
• Additional country or region analysis- market size and forecast
• Average Selling Price Analysis / Price Point Analysis
• Expanded list for Company Profiles
• Historic market data

Key Market Segments

By Type

• Synthetic Adhesion Barrier
• Natural Adhesion Barrier

By Application

• General/Abdominal Surgeries
• Gynecological Surgeries
• Cardiovascular Surgeries
• Orthopedic Surgeries
• Neurological Surgeries
• Other Applications

By End User

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players:

• Anika Therapeutics Inc.
• Baxter International Inc.
• leader biomedical
• Betatech Medical
• fziomed, inc.
• Integra LifeSciences Holdings Corporation
• Johnson & Johnson
• CGBio Inc
• Atrium Medical Corporation
• Toray Industries Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report Description
• 1.2. Key Market Segments
• 1.3. Key Benefits
• 1.4. Research Methodology
  • 1.4.1. Primary Research
  • 1.4.2. Secondary Research
  • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

• 3.1. Market Definition and Scope
• 3.2. Key Findings
  • 3.2.1. Top Investment Pockets
  • 3.2.2. Top Winning Strategies
• 3.3. Porter's Five Forces Analysis
  • 3.3.1. Bargaining Power of Suppliers
  • 3.3.2. Threat of New Entrants
  • 3.3.3. Threat of Substitutes
  • 3.3.4. Competitive Rivalry
  • 3.3.5. Bargaining Power among Buyers
• 3.4. Market Dynamics
  • 3.4.1. Drivers
  • 3.4.2. Restraints
  • 3.4.3. Opportunities

CHAPTER 4: ADHESION BARRIER MARKET, BY TYPE

• 4.1. Market Overview
  • 4.1.1 Market Size and Forecast, By Type
• 4.2. Synthetic Adhesion Barrier
  • 4.2.1. Key Market Trends, Growth Factors and Opportunities
  • 4.2.2. Market Size and Forecast, By Region
  • 4.2.3. Market Share Analysis, By Country
• 4.3. Natural Adhesion Barrier
  • 4.3.1. Key Market Trends, Growth Factors and Opportunities
  • 4.3.2. Market Size and Forecast, By Region
  • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: ADHESION BARRIER MARKET, BY APPLICATION

• 5.1. Market Overview
  • 5.1.1 Market Size and Forecast, By Application
• 5.2. General/Abdominal Surgeries
  • 5.2.1. Key Market Trends, Growth Factors and Opportunities
  • 5.2.2. Market Size and Forecast, By Region
  • 5.2.3. Market Share Analysis, By Country
• 5.3. Gynecological Surgeries
  • 5.3.1. Key Market Trends, Growth Factors and Opportunities
  • 5.3.2. Market Size and Forecast, By Region
  • 5.3.3. Market Share Analysis, By Country
• 5.4. Cardiovascular Surgeries
  • 5.4.1. Key Market Trends, Growth Factors and Opportunities
  • 5.4.2. Market Size and Forecast, By Region
  • 5.4.3. Market Share Analysis, By Country
• 5.5. Orthopedic Surgeries
  • 5.5.1. Key Market Trends, Growth Factors and Opportunities
  • 5.5.2. Market Size and Forecast, By Region
  • 5.5.3. Market Share Analysis, By Country
• 5.6. Neurological Surgeries
  • 5.6.1. Key Market Trends, Growth Factors and Opportunities
  • 5.6.2. Market Size and Forecast, By Region
  • 5.6.3. Market Share Analysis, By Country
• 5.7. Other Applications
  • 5.7.1. Key Market Trends, Growth Factors and Opportunities
  • 5.7.2. Market Size and Forecast, By Region
  • 5.7.3. Market Share Analysis, By Country

CHAPTER 6: ADHESION BARRIER MARKET, BY END USER

• 6.1. Market Overview
  • 6.1.1 Market Size and Forecast, By End User
• 6.2. Hospitals
  • 6.2.1. Key Market Trends, Growth Factors and Opportunities
  • 6.2.2. Market Size and Forecast, By Region
  • 6.2.3. Market Share Analysis, By Country
• 6.3. Specialty Clinics
  • 6.3.1. Key Market Trends, Growth Factors and Opportunities
  • 6.3.2. Market Size and Forecast, By Region
  • 6.3.3. Market Share Analysis, By Country
• 6.4. Ambulatory Surgical Centers
  • 6.4.1. Key Market Trends, Growth Factors and Opportunities
  • 6.4.2. Market Size and Forecast, By Region
  • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: ADHESION BARRIER MARKET, BY REGION

• 7.1. Market Overview
  • 7.1.1 Market Size and Forecast, By Region
• 7.2. North America
  • 7.2.1. Key Market Trends and Opportunities
  • 7.2.2. Market Size and Forecast, By Type
  • 7.2.3. Market Size and Forecast, By Application
  • 7.2.4. Market Size and Forecast, By End User
  • 7.2.5. Market Size and Forecast, By Country
  • 7.2.6. U.S. Adhesion Barrier Market
    • 7.2.6.1. Market Size and Forecast, By Type
    • 7.2.6.2. Market Size and Forecast, By Application
    • 7.2.6.3. Market Size and Forecast, By End User
  • 7.2.7. Canada Adhesion Barrier Market
    • 7.2.7.1. Market Size and Forecast, By Type
    • 7.2.7.2. Market Size and Forecast, By Application
    • 7.2.7.3. Market Size and Forecast, By End User
  • 7.2.8. Mexico Adhesion Barrier Market
    • 7.2.8.1. Market Size and Forecast, By Type
    • 7.2.8.2. Market Size and Forecast, By Application
    • 7.2.8.3. Market Size and Forecast, By End User
• 7.3. Europe
  • 7.3.1. Key Market Trends and Opportunities
  • 7.3.2. Market Size and Forecast, By Type
  • 7.3.3. Market Size and Forecast, By Application
  • 7.3.4. Market Size and Forecast, By End User
  • 7.3.5. Market Size and Forecast, By Country
  • 7.3.6. Germany Adhesion Barrier Market
    • 7.3.6.1. Market Size and Forecast, By Type
    • 7.3.6.2. Market Size and Forecast, By Application
    • 7.3.6.3. Market Size and Forecast, By End User
  • 7.3.7. France Adhesion Barrier Market
    • 7.3.7.1. Market Size and Forecast, By Type
    • 7.3.7.2. Market Size and Forecast, By Application
    • 7.3.7.3. Market Size and Forecast, By End User
  • 7.3.8. UK Adhesion Barrier Market
    • 7.3.8.1. Market Size and Forecast, By Type
    • 7.3.8.2. Market Size and Forecast, By Application
    • 7.3.8.3. Market Size and Forecast, By End User
  • 7.3.9. Italy Adhesion Barrier Market
    • 7.3.9.1. Market Size and Forecast, By Type
    • 7.3.9.2. Market Size and Forecast, By Application
    • 7.3.9.3. Market Size and Forecast, By End User
  • 7.3.10. Spain Adhesion Barrier Market
    • 7.3.10.1. Market Size and Forecast, By Type
    • 7.3.10.2. Market Size and Forecast, By Application
    • 7.3.10.3. Market Size and Forecast, By End User
  • 7.3.11. Rest of Europe Adhesion Barrier Market
    • 7.3.11.1. Market Size and Forecast, By Type
    • 7.3.11.2. Market Size and Forecast, By Application
    • 7.3.11.3. Market Size and Forecast, By End User
• 7.4. Asia-Pacific
  • 7.4.1. Key Market Trends and Opportunities
  • 7.4.2. Market Size and Forecast, By Type
  • 7.4.3. Market Size and Forecast, By Application
  • 7.4.4. Market Size and Forecast, By End User
  • 7.4.5. Market Size and Forecast, By Country
  • 7.4.6. Japan Adhesion Barrier Market
    • 7.4.6.1. Market Size and Forecast, By Type
    • 7.4.6.2. Market Size and Forecast, By Application
    • 7.4.6.3. Market Size and Forecast, By End User
  • 7.4.7. China Adhesion Barrier Market
    • 7.4.7.1. Market Size and Forecast, By Type
    • 7.4.7.2. Market Size and Forecast, By Application
    • 7.4.7.3. Market Size and Forecast, By End User
  • 7.4.8. Australia Adhesion Barrier Market
    • 7.4.8.1. Market Size and Forecast, By Type
    • 7.4.8.2. Market Size and Forecast, By Application
    • 7.4.8.3. Market Size and Forecast, By End User
  • 7.4.9. India Adhesion Barrier Market
    • 7.4.9.1. Market Size and Forecast, By Type
    • 7.4.9.2. Market Size and Forecast, By Application
    • 7.4.9.3. Market Size and Forecast, By End User
  • 7.4.10. South Korea Adhesion Barrier Market
    • 7.4.10.1. Market Size and Forecast, By Type
    • 7.4.10.2. Market Size and Forecast, By Application
    • 7.4.10.3. Market Size and Forecast, By End User
  • 7.4.11. Rest of Asia-Pacific Adhesion Barrier Market
    • 7.4.11.1. Market Size and Forecast, By Type
    • 7.4.11.2. Market Size and Forecast, By Application
    • 7.4.11.3. Market Size and Forecast, By End User
• 7.5. LAMEA
  • 7.5.1. Key Market Trends and Opportunities
  • 7.5.2. Market Size and Forecast, By Type
  • 7.5.3. Market Size and Forecast, By Application
  • 7.5.4. Market Size and Forecast, By End User
  • 7.5.5. Market Size and Forecast, By Country
  • 7.5.6. Brazil Adhesion Barrier Market
    • 7.5.6.1. Market Size and Forecast, By Type
    • 7.5.6.2. Market Size and Forecast, By Application
    • 7.5.6.3. Market Size and Forecast, By End User
  • 7.5.7. Saudi Arabia Adhesion Barrier Market
    • 7.5.7.1. Market Size and Forecast, By Type
    • 7.5.7.2. Market Size and Forecast, By Application
    • 7.5.7.3. Market Size and Forecast, By End User
  • 7.5.8. South Africa Adhesion Barrier Market
    • 7.5.8.1. Market Size and Forecast, By Type
    • 7.5.8.2. Market Size and Forecast, By Application
    • 7.5.8.3. Market Size and Forecast, By End User
  • 7.5.9. Rest of LAMEA Adhesion Barrier Market
    • 7.5.9.1. Market Size and Forecast, By Type
    • 7.5.9.2. Market Size and Forecast, By Application
    • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

• 8.1. Introduction
• 8.2. Top Winning Strategies
• 8.3. Product Mapping of Top 10 Player
• 8.4. Competitive Dashboard
• 8.5. Competitive Heatmap
• 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

• 9.1. Anika Therapeutics Inc.
  • 9.1.1. Company Overview
  • 9.1.2. Key Executives
  • 9.1.3. Company Snapshot
  • 9.1.4. Operating Business Segments
  • 9.1.5. Product Portfolio
  • 9.1.6. Business Performance
  • 9.1.7. Key Strategic Moves and Developments
• 9.2. Baxter International Inc.
  • 9.2.1. Company Overview
  • 9.2.2. Key Executives
  • 9.2.3. Company Snapshot
  • 9.2.4. Operating Business Segments
  • 9.2.5. Product Portfolio
  • 9.2.6. Business Performance
  • 9.2.7. Key Strategic Moves and Developments
• 9.3. Leader Biomedical
  • 9.3.1. Company Overview
  • 9.3.2. Key Executives
  • 9.3.3. Company Snapshot
  • 9.3.4. Operating Business Segments
  • 9.3.5. Product Portfolio
  • 9.3.6. Business Performance
  • 9.3.7. Key Strategic Moves and Developments
• 9.4. Betatech Medical
  • 9.4.1. Company Overview
  • 9.4.2. Key Executives
  • 9.4.3. Company Snapshot
  • 9.4.4. Operating Business Segments
  • 9.4.5. Product Portfolio
  • 9.4.6. Business Performance
  • 9.4.7. Key Strategic Moves and Developments
• 9.5. Fziomed, Inc.
  • 9.5.1. Company Overview
  • 9.5.2. Key Executives
  • 9.5.3. Company Snapshot
  • 9.5.4. Operating Business Segments
  • 9.5.5. Product Portfolio
  • 9.5.6. Business Performance
  • 9.5.7. Key Strategic Moves and Developments
• 9.6. Integra LifeSciences Holdings Corporation
  • 9.6.1. Company Overview
  • 9.6.2. Key Executives
  • 9.6.3. Company Snapshot
  • 9.6.4. Operating Business Segments
  • 9.6.5. Product Portfolio
  • 9.6.6. Business Performance
  • 9.6.7. Key Strategic Moves and Developments
• 9.7. Johnson And Johnson
  • 9.7.1. Company Overview
  • 9.7.2. Key Executives
  • 9.7.3. Company Snapshot
  • 9.7.4. Operating Business Segments
  • 9.7.5. Product Portfolio
  • 9.7.6. Business Performance
  • 9.7.7. Key Strategic Moves and Developments
• 9.8. CGBio Inc
  • 9.8.1. Company Overview
  • 9.8.2. Key Executives
  • 9.8.3. Company Snapshot
  • 9.8.4. Operating Business Segments
  • 9.8.5. Product Portfolio
  • 9.8.6. Business Performance
  • 9.8.7. Key Strategic Moves and Developments
• 9.9. Atrium Medical Corporation
  • 9.9.1. Company Overview
  • 9.9.2. Key Executives
  • 9.9.3. Company Snapshot
  • 9.9.4. Operating Business Segments
  • 9.9.5. Product Portfolio
  • 9.9.6. Business Performance
  • 9.9.7. Key Strategic Moves and Developments
• 9.10. Toray Industries Inc.
  • 9.10.1. Company Overview
  • 9.10.2. Key Executives
  • 9.10.3. Company Snapshot
  • 9.10.4. Operating Business Segments
  • 9.10.5. Product Portfolio
  • 9.10.6. Business Performance
  • 9.10.7. Key Strategic Moves and Developments